Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice
Dipak Panigrahy, … , Mark W. Kieran, Darryl C. Zeldin
Dipak Panigrahy, … , Mark W. Kieran, Darryl C. Zeldin
Published December 19, 2011
Citation Information: J Clin Invest. 2012;122(1):178-191. https://doi.org/10.1172/JCI58128.
View: Text | PDF
Research Article Article has an altmetric score of 21

Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice

  • Text
  • PDF
Abstract

Epoxyeicosatrienoic acids (EETs) are small molecules produced by cytochrome P450 epoxygenases. They are lipid mediators that act as autocrine or paracrine factors to regulate inflammation and vascular tone. As a result, drugs that raise EET levels are in clinical trials for the treatment of hypertension and many other diseases. However, despite their pleiotropic effects on cells, little is known about the role of these epoxyeicosanoids in cancer. Here, using genetic and pharmacological manipulation of endogenous EET levels, we demonstrate that EETs are critical for primary tumor growth and metastasis in a variety of mouse models of cancer. Remarkably, we found that EETs stimulated extensive multiorgan metastasis and escape from tumor dormancy in several tumor models. This systemic metastasis was not caused by excessive primary tumor growth but depended on endothelium-derived EETs at the site of metastasis. Administration of synthetic EETs recapitulated these results, while EET antagonists suppressed tumor growth and metastasis, demonstrating in vivo that pharmacological modulation of EETs can affect cancer growth. Furthermore, inhibitors of soluble epoxide hydrolase (sEH), the enzyme that metabolizes EETs, elevated endogenous EET levels and promoted primary tumor growth and metastasis. Thus, our data indicate a central role for EETs in tumorigenesis, offering a mechanistic link between lipid signaling and cancer and emphasizing the critical importance of considering possible effects of EET-modulating drugs on cancer.

Authors

Dipak Panigrahy, Matthew L. Edin, Craig R. Lee, Sui Huang, Diane R. Bielenberg, Catherine E. Butterfield, Carmen M. Barnés, Akiko Mammoto, Tadanori Mammoto, Ayala Luria, Ofra Benny, Deviney M. Chaponis, Andrew C. Dudley, Emily R. Greene, Jo-Anne Vergilio, Giorgio Pietramaggiori, Sandra S. Scherer-Pietramaggiori, Sarah M. Short, Meetu Seth, Fred B. Lih, Kenneth B. Tomer, Jun Yang, Reto A. Schwendener, Bruce D. Hammock, John R. Falck, Vijaya L. Manthati, Donald E. Ingber, Arja Kaipainen, Patricia A. D’Amore, Mark W. Kieran, Darryl C. Zeldin

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 Total
Citations: 6 15 7 12 18 19 14 9 12 11 8 18 17 7 1 1 175
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2019 (14)

Title and authors Publication Year
Pre-operative stimulation of resolution and inflammation blockade eradicates micrometastases
Dipak Panigrahy, Allison Gartung, Jun Yang, Haixia Yang, Molly M. Gilligan, Megan L. Sulciner, Swati S Bhasin, Diane R. Bielenberg, Jaimie Chang, Birgitta A. Schmidt, Julia Piwowarski, Anna Fishbein, Dulce Soler-Ferran, Matthew A. Sparks, Steven J. Staffa, Vidula Sukhatme, Bruce D. Hammock, Mark W. Kieran, Sui Huang, Manoj Bhasin, Charles N. Serhan, Vikas P. Sukhatme
Journal of Clinical Investigation 2019
New Lipid Mediators in Retinal Angiogenesis and Retinopathy
I Fleming
Frontiers in pharmacology 2019
Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion
P Kreuzaler, Y Panina, J Segal, M Yuneva
Molecular Metabolism 2019
Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer
MK Apaya, JY Shiau, GS Liao, YJ Liang, CW Chen, HC Yang, CH Chu, JC Yu, LF Shyur
Journal of Experimental & Clinical Cancer Research 2019
Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications
F Rossari, C Zucchinetti, G Buda, E Orciuolo
Cellular Oncology 2019
Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
B Park, TW Corson
Frontiers in pharmacology 2019
Aspirin-triggered proresolving mediators stimulate resolution in cancer
MM Gilligan, A Gartung, ML Sulciner, PC Norris, VP Sukhatme, DR Bielenberg, S Huang, MW Kieran, CN Serhan, D Panigrahy
Proceedings of the National Academy of Sciences 2019
Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis
X Zhuang, H Zhang, G Hu
Trends in Pharmacological Sciences 2019
Targeted Metabolomics Identifies the Cytochrome P450 Monooxygenase Eicosanoid Pathway as a Novel Therapeutic Target of Colon Tumorigenesis
W Wang, J Yang, ML Edin, Y Wang, Y Luo, D Wan, H Yang, CQ Song, W Xue, KZ Sanidad, M Song, HA Bisbee, JA Bradbury, G Nan, J Zhang, PB Shih, KS Lee, LM Minter, D Kim, H Xiao, JY Liu, BD Hammock, DC Zeldin, G Zhang
Cancer research 2019
Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis
RD Jones, J Liao, X Tong, D Xu, L Sun, H Li, GY Yang
Frontiers in pharmacology 2019
Cancer cell population growth kinetics at low densities deviate from the exponential growth model and suggest an Allee effect
KE Johnson, G Howard, W Mo, MK Strasser, EA Lima, S Huang, A Brock, AF Read
PLoS Biology 2019
Impact of the acute local inhibition of soluble epoxide hydrolase on diabetic skin microcirculatory dysfunction
Y Savina, T Duflot, F Bounoure, S Kotzki, PA Thiebaut, PA Serreau, M Skiba, JM Picquenot, M Cornic, C Morisseau, B Hammock, L Imbert, JL Cracowski, V Richard, M Roustit, J Bellien
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2019
Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase
XIA R, SUN L, LIAO J, LI H, YOU X, XU D, YANG J, HWANG SH, JONES RD, HAMMOCK B, YANG GY
Anticancer research 2019
Cytochrome P450 monooxygenase/soluble epoxide hydrolase-mediated eicosanoid pathway in colorectal cancer and obesity-associated colorectal cancer.
Zhang J, Sanidad KZ, Zhang G
Oncoscience 2019

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 2
Posted by 5 X users
Referenced in 4 patents
Highlighted by 1 platforms
143 readers on Mendeley
See more details